{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T19:58:40Z","timestamp":1709582320362},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00432-009-0670-9","type":"journal-article","created":{"date-parts":[[2009,8,31]],"date-time":"2009-08-31T04:51:40Z","timestamp":1251694300000},"page":"403-410","source":"Crossref","is-referenced-by-count":12,"title":["Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status"],"prefix":"10.1007","volume":"136","author":[{"given":"Alexander","family":"Hoellein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madlen","family":"Oelsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Hauswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Peschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Licht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,1]]},"reference":[{"key":"670_CR1","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood-2006-09-047621","volume":"109","author":"C Andreadis","year":"2007","unstructured":"Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR (2007) Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood 109:3409\u20133416","journal-title":"Blood"},{"key":"670_CR2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00277-005-0076-y","volume":"85","author":"C Bogner","year":"2006","unstructured":"Bogner C, Sandherr M, Perker M, Weick K, Ringshausen I, Peschel C, Decker T (2006) Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells. Ann Hematol 85:458\u2013462","journal-title":"Ann Hematol"},{"key":"670_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2141.1999.01516.x","volume":"106","author":"AG Bosanquet","year":"1999","unstructured":"Bosanquet AG, Johnson SA, Richards SM (1999) Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. Br J Haematol 106:71\u201377","journal-title":"Br J Haematol"},{"key":"670_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(91)90141-K","volume":"66","author":"PM Chaudhary","year":"1991","unstructured":"Chaudhary PM, Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85\u201394","journal-title":"Cell"},{"key":"670_CR5","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","volume":"100","author":"L Chen","year":"2002","unstructured":"Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, Kipps TJ (2002) Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 100:4609\u20134614","journal-title":"Blood"},{"key":"670_CR6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764\u20131775","journal-title":"N Engl J Med"},{"key":"670_CR7","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","volume":"99","author":"RN Damle","year":"2002","unstructured":"Damle RN, Ghiotto F, Valetto A, Albesiano E, Fais F, Yan XJ, Sison CP, Allen SL, Kolitz J, Schulman P, Vinciguerra VP, Budde P, Frey J, Rai KR, Ferrarini M, Chiorazzi N (2002) B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99:4087\u20134093","journal-title":"Blood"},{"key":"670_CR8","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2003-04-1317","volume":"103","author":"T Decker","year":"2004","unstructured":"Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang QC, Pastan I, Peschel C, Licht T (2004) Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood 103:2718\u20132726","journal-title":"Blood"},{"key":"670_CR9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood-2005-12-4986","volume":"108","author":"MI Del Principe","year":"2006","unstructured":"Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo Coco F, Del Principe D, Amadori S (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 108:853\u2013861","journal-title":"Blood"},{"key":"670_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","volume":"84","author":"AT Fojo","year":"1987","unstructured":"Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265\u2013269","journal-title":"Proc Natl Acad Sci USA"},{"key":"670_CR11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/81.2.116","volume":"81","author":"LJ Goldstein","year":"1989","unstructured":"Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116\u2013124","journal-title":"J Natl Cancer Inst"},{"key":"670_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48\u201358","journal-title":"Nat Rev Cancer"},{"key":"670_CR13","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1080\/10428190701457931","volume":"48","author":"N Guillaume","year":"2007","unstructured":"Guillaume N, Gouilleux-Gruart V, Claisse JF, Troussard X, Lepelley P, Damaj G, Royer B, Garidi R, Lefrere JJ (2007) Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70\/CD38 expression in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 48:1556\u20131560","journal-title":"Leuk Lymphoma"},{"key":"670_CR14","doi-asserted-by":"crossref","first-page":"29509","DOI":"10.1074\/jbc.M304059200","volume":"278","author":"Y Guo","year":"2003","unstructured":"Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD (2003) MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2\u2032, 3\u2032-dideoxycytidine and 9\u2032-(2\u2032-phosphonylmethoxyethyl)adenine. J Biol Chem 278:29509\u201329514","journal-title":"J Biol Chem"},{"key":"670_CR15","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines. Blood 111:5446\u20135456","journal-title":"Blood"},{"key":"670_CR16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848\u20131854","journal-title":"Blood"},{"key":"670_CR17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jnci\/82.13.1133","volume":"82","author":"H Herweijer","year":"1990","unstructured":"Herweijer H, Sonneveld P, Baas F, Nooter K (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82:1133\u20131140","journal-title":"J Natl Cancer Inst"},{"key":"670_CR18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00277-004-0855-x","volume":"83","author":"M Jerkeman","year":"2004","unstructured":"Jerkeman M, Anderson H, Dictor M, Kvaloy S, Akerman M, Cavallin-Stahl E (2004) Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma\u2014a Nordic Lymphoma Group study. Ann Hematol 83:414\u2013419","journal-title":"Ann Hematol"},{"key":"670_CR19","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1080\/10428190600881421","volume":"47","author":"C Matthews","year":"2006","unstructured":"Matthews C, Catherwood MA, Larkin AM, Clynes M, Morris TC, Alexander HD (2006) MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia. Leuk Lymphoma 47:2308\u20132313","journal-title":"Leuk Lymphoma"},{"key":"670_CR20","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2002-07-2236","volume":"101","author":"M Molina-Arcas","year":"2003","unstructured":"Molina-Arcas M, Bellosillo B, Casado FJ, Montserrat E, Gil J, Colomer D, Pastor-Anglada M (2003) Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood 101:2328\u20132334","journal-title":"Blood"},{"key":"670_CR21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.2910450409","volume":"45","author":"K Nooter","year":"1990","unstructured":"Nooter K, Sonneveld P, Janssen A, Oostrum R, Boersma T, Herweijer H, Valerio D, Hagemeijer A, Baas F (1990) Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation. Int J Cancer 45:626\u2013631","journal-title":"Int J Cancer"},{"key":"670_CR22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000086984","volume":"68","author":"M Ohsawa","year":"2005","unstructured":"Ohsawa M, Ikura Y, Fukushima H, Shirai N, Sugama Y, Suekane T, Hirayama M, Hino M, Ueda M (2005) Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma. Oncology 68:422\u2013431","journal-title":"Oncology"},{"key":"670_CR23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2141.1999.01210.x","volume":"104","author":"C Pepper","year":"1999","unstructured":"Pepper C, Thomas A, Hoy T, Bentley P (1999) Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones. Br J Haematol 104:581\u2013588","journal-title":"Br J Haematol"},{"key":"670_CR24","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1074\/jbc.M007746200","volume":"276","author":"MW Ritzel","year":"2001","unstructured":"Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen XZ, Karpinski E, Hyde RJ, Baldwin SA, Cass CE, Young JD (2001) Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914\u20132927","journal-title":"J Biol Chem"},{"key":"670_CR25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639\u20131647","journal-title":"J Exp Med"},{"key":"670_CR26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2141.2004.05319.x","volume":"128","author":"M Schaich","year":"2005","unstructured":"Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T (2005) MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. Br J Haematol 128:324\u2013332","journal-title":"Br J Haematol"},{"key":"670_CR27","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1016\/S0021-9258(19)57466-X","volume":"261","author":"DW Shen","year":"1986","unstructured":"Shen DW, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, Gottesman MM (1986) Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261:7762\u20137770","journal-title":"J Biol Chem"},{"key":"670_CR28","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.V79.6.1496.1496","volume":"79","author":"P Sonneveld","year":"1992","unstructured":"Sonneveld P, Nooter K, Burghouts JT, Herweijer H, Adriaansen HJ, van Dongen JJ (1992) High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood 79:1496\u20131500","journal-title":"Blood"},{"key":"670_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/icb.1997.17","volume":"75","author":"SG Tangye","year":"1997","unstructured":"Tangye SG, Raison RL (1997) Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2. Immunol Cell Biol 75:127\u2013135","journal-title":"Immunol Cell Biol"},{"key":"670_CR30","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944\u20134951","journal-title":"Blood"},{"key":"670_CR31","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1080\/10428190600634036","volume":"47","author":"CS Zent","year":"2006","unstructured":"Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE (2006) Update on risk-stratified management for chronic lymphocytic leukemia. Leuk Lymphoma 47:1738\u20131746","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0670-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0670-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0670-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:06:02Z","timestamp":1633845962000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0670-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0670-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,1]]}}}